Neurotransmission alterations in central cardiovascular control in experimental hypertesion

Current Hypertension Reviews

Volumn 2, Issue 3, 2006, Pages 193-198

  de Campos, Ruy Ribeiro ^a   Bergamaschi, Cassia T ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin II; GABA; Glutamate; Paraventricular nucleus; Sympathetic nervous system; Ventrolateral medulla

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN II ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUTAMIC ACID;

ADRENERGIC ACTIVITY; ADRENERGIC TRANSMISSION; ANTIHYPERTENSIVE ACTIVITY; AREA POSTREMA; ARTERIAL PRESSURE; CARDIOVASCULAR AUTOREGULATION; CARDIOVASCULAR REFLEX; CATECHOLAMINE RELEASE; GABAERGIC TRANSMISSION; HUMAN; HYPERTENSION; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; LOW DRUG DOSE; MEDULLA OBLONGATA; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; PREMOTOR CORTEX; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; REVIEW; SYMPATHETIC NERVE CELL; VASOMOTOR REFLEX;

EID: 33748115334     PISSN: 15734021     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340206778132590     Document Type: Review

References (67)

1. Veerasingham SJ, Raizada MK. Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharmacol 2003; 139: 191-202.
2. Grimson K. Total thoracic and partial to total lumbar sympathectomy and celiac ganglionectomy in the treatment of hypertension. Ann Surg 1941; 114: 753-775.
3. Smithwick RH. A technique for splanchnic resection for hypertension. Surgery 1940; 7: 1-8.
4. Brooks VL, Sved AF. Pressure to change? Re-evaluating the role of baroreceptors in the long-term control of arterial pressure. Am J Physiol Regul Integr Comp Physiol 2005; 288: R815-18.
5. Colombari E, Sato MA, Cravo SL, Bergamaschi CT, Campos RR, Lopes OU. Role of the medulla oblongata in hypertension. Hypertension 2001; 38(2): 549-54.
6. Guyton AC. Renal function curves and control of body fluids and arterial pressure. Acta Physiol Scand 1990; 139 (591): 107-13.
7. Osborn JW. Hypothesis: Set points and long-term control of arterial pressure. A theoretical argument for a long-term arterial pressure control system in the brain rather than the kidney. Clin Exp Phamacol Physiol 2005; 32: 384-93.
8. Dampney RAL, Horiuchi J, Killinger S, Sheriff MJ, Tan PSP, McDowall LM. Long-term regulation of arterial blood pressure by hypothalamic nuclei: some critical questions. Clin Exp Phamacol Physiol 2005; 32: 419-25.
9. Esler M, Jennings G, Lambert G. Noradrenaline release and the pathophysiology of primary human hypertension. Am J Hypertens 1989; 2: 140S-46.
10. Esler M, Lambert G, Jennings G. Increased regional sympathetic nervous activity in human hypertension: causes and consequences. J Hypertens 1990; 8: S53-57.
11. Mark AL. The sympathetic nervous system in hypertension: a potential long-term regulator of arterial pressure. J Hypertension 1996; 14: S159-65.
12. De Wardener H. The hypothalamus and hypertension. Physiol Rev 2001; 81: 1559-658.
13. Greenwood JP, Stoker JB, Mary D. Single unit sympathetic discharge: Quantitative assessment in human hypertensive disease. Circ Res 1999; 100: 1305-10.
14. Mary D. The activity of single vasoconstrictor nerve units in hypertension. Acts Physiol Scand 2003; 177: 367-76.
15. Dampney RAL, Horiuchi J, Tagawa T, Fontes MAP, Potts PD, Polson JW. Medullary and supramedullary mechanisms regulating sympathetic vasomotor tone. Acta Physiol Scand 2003; 177: 209-18.
16. Dampney RAL. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 1994; 74: 323-64.
17. Campos RR, Guertzenstein PG. Role of the glycine sensitive area in the regulation of cardiac output. Prog Brain Res 1989; 81: 243-51.
18. Campos RR, McAllen RM. Cardiac inotropic, chronotropic, and dromotropic actions of subretrofacial neurons of cat RVLM. Am J Physiol Reg Integr Comp Physiol 1999; 45: R1102-111.
19. Ernsberger P, Meeley MP, Mann JJ, Reis DJ. Clonidine binds to imidazole binding sites as well as α2-adrenoceptors in the ventrolateral medulla. Eur J Pharmacol 1987; 134:1-13.
20. Doba N, Reis DJ. Acute fulminating neurogenic hypertension produced by brainstem lesions in the rat. Circ Res 1973; 32: 584-93.
21. Blessing WW, Reis DJ. Inhibitory cardiovascular function of neurons in the caudal ventrolateral medulla of the rabbit: relationship to the area containing A1 noradrenergic cells. Brain Res 1982; 253: 161-71.
22. Chalmers J, Arnolda L, Kapoor V, Llewellyn-Smith I, Minson J, Pilowsky P. Amino acid neurotransmitters in the central control of blood pressure and in experimental hypertension. J Hypertens 1992; 10: S27-37.
23. Chan R, Chan Y, Won T. Electrophysiological properties of neurons in the rostral ventrolateral medulla of normotensive and spontaneously hypertensive rats. Brain Res 1991; 549: 118-26.
24. Bergamaschi CT, Campos RR, Schor N, Lopes OU. Role of the rostral ventrolateral medulla in maintenance of blood pressure in rats with Goldblatt hypertension. Hypertension 1995; 26 (part 2): 1117-120.
25. Allen AM, Dampney RA, Mendelsohn, FA. Angiotensin receptor binding and pressor effects in cat subretrofacial nucleus. Am J Physiol Heart Circ Physiol 1988; 255: H1011-17.
26. Andreatta SH, Averill DB, Santos RAS, Ferrario CM. The ventrolateral medulla: A new site of the action of the renin-angiotensin system. Hypertension 1988; 11(Suppl. 1): I163-66.
27. Sakai S, Dampney RAL. Tonic cardiovascular effects of angiotensin II in the ventrolateral medulla. Hypertension 1990; 15: 274-83.
28. Averill DB, Tsuchihashi T, Khosla C, Ferrario CM. Losartan, nonpeptide angiotensin II type 1 (AT1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla. Brain Research 1994; 665: 245-52.
29. Ito S, Sved AF. Blockade of angiotensin receptors in rat rostral ventrolateral medulla severely reduces sympathetic vasomotor tone. Am J Physiol Reg Integr Comp Physiol 1996; 270: R1317-23.
30. Ito S, Komatsu K, Tsukamoto K, Sved AF. Excitatory amino acids in the rostral ventrolateral medulla support blood pressure in spontaneously rats. Hypertension 2000; 35: 413-17.
31. Ito S, Komatsu K, Tsukamoto K, Sved AF. Tonic excitatory input to the rostral ventrolateral medulla in Dahl salt-sensitive rats. Hypertension 2001; 37: 687-91.
32. Morimoto S, Sasaki S, Miki S, Kawa T, Nakamura K, Ichida T, et al. Pressor response to compression of the ventrolateral medulla mediated by glutamate receptors. Hypertension 1999; 33: 1207-13.
33. Carvalho TH, Bergamaschi CT, Lopes OU, Campos RR. Role of endogenous angiotensin II on glutamatergic actions in the rostral ventrolateral medulla in Goldblatt hypertensive rats. Hypertension; 2003; 42 (4): 707-12.
34. Katahira K, Mikami A, Otsuka A. Differential control of vascular tone and heart rate by different amino acid neuro-transmitters in the rostral ventrolateral medulla of the rat. Chn Exp Phamacol Physiol 1994; 21: 545-56.
35. Moriguchi A, Mikami H, Otsuka A, Katahira K, Ogihara T. Amino acids in the medulla oblongata contribute to baroreflex modulation by angiotensin II. Brain Res Bull 1994; 36: 85-9.
36. Van HM, Schiffrin EL, Mann JFE, Posner BI, Boucher R. Radioautographic localization of specific binding sites for blood home angiotensin II in rat brain. Brain Res 1980; 186: 480-5.
37. Fink GD. Long-term sympatho-excitatory effect of angiotensin II: a mechanism of spontaneous and renovascular hypertension. Clin Exp Phamacol Physiol 1997; 24: 91-5.
38. Ferguson AV, Washburn DL, Latchford KJ. Hormonal and neurotransmitter roles for angiotensin in the regulation of central autonomic function. Exp Biol Med 2001; 226: 85-96.
39. Paton JF, Boscan P, Murphy D, Kasparov S. Unravelling mechanisms of action of angiotensin II on cardiorespiratory function using in vivo gene transfer. Acta Physiol Scand 2001; 173: 127-37.
40. Paton JF, Kasparovo S. Differential effects of angiotensin II on cardiorespiratory reflexes mediated by nucleus tractus solitarii - a microinjection study in the rat. J Physiol 1999; 521: 213-25.
41. Joy MD, Lowe RD. Evidence that the area postrema mediates the central cardiovascular response to angiotensin II. Nature 1970; 228: 1303-04.
42. Fink GD, Bruner CA, Mangiapane ML. Area postrema is critical for angiotensin-induced hypertension in rats. Hypertension 1987; 9: 355-61.
43. Brooks VL, Freeman KL, O'Donaughy TL. Acute and chronic increases in osmolality increase excitatory amino acid drive of the rostral ventrolateral medulla in rats. Am J Physiol Regul Integr Comp Physiol 2004; 287: R1359-68.
44. Lipski J, Kanjhan R, Kruszewska B, Rong W. Properties of presympathetic neurons in the rostral ventrolateral medulla in the rat: an intracellular study "in vivo". J Physiol 1996; 490: 729-44.
45. Zhu DN, Moriguchi A, Mikami H, Higaki J, Ogihara T. Central amino acids mediate cardiovascular response to angiotensin II in the rat. Brain Res Bull 1998, 45: 189-97.
46. Stocker SD, Keith KJ, Toney GM. Acute inhibition of the hypothalamic paraventricular nucleus decreases renal sympathetic nerve activity and arterial blood pressure in water-deprived rats. Am J Physiol Regul Integr Comp Physiol 2004; 286: R719-25.
47. Wible JHJr, DiMicco JA, Luft FC. Hypothalamic GABA and sympathetic regulation in spontaneously hypertensive rats. Hypertension 1989; 14: 623-28.
48. Martin DS, Segura T, Haywood JR. Cardiovascular responses to bicuculline in the paraventricular nucleus of the rat. Hypertension 1991; 18: 48-55.
49. Kannan H, Hayashida Y, Yamashita H. Increase in sympathetic outflow by paraventricular nucleus stimulation in awake rats. Am J Physiol Regul Integr Comp Physiol 1989; 256: R1325-30.
50. Yang Z, Coote JH. Influence of the hypothalamic paraventricular nucleus on cardiovascular neurons in the rostral ventrolateral medulla of the rat. J Physiol 1998; 513: 521-30.
51. Silva AQ, Santos RA, Fontes MA. Blockade of endogenous angiotensin-(1-7) in the hypothalamic paraventricular nucleus reduces renal sympathetic tone. Hypertension 2005; 46 (2): 341-48.
52. Allen AM. Inhibition of the hypothalamic paraventricular nucleus in spontaneously hypertensive rats dramatically reduces sympathetic vasomotor tone. Hypertension 2002; 39: 275-80.
53. Strack AM, Sawyer WB, Hughes JH, Platt KB, Loewy AD. A general pattern of CNS innervation of the sympathetic outflow demonstrated by transneuronal pseudorabies viral infections. Brain Res 1989; 491: 156-62.
54. Ciriello J, Kline RL, Zhang TX, Caverson MM. Lesions of the paraventricular nucleus alter the development of spontaneous hypertension in the rat. Brain Res 1984; 310: 355-59.
55. Takeda K, Nakata T, Takesako T, Itoh H, Hirata M, Kawasaki S, et al. Sympathetic inhibition and attenuation of spontaneous hypertension by PVN lesions in rats. Brain Res 1991; 543: 296-300.
56. Herzig TC, Buchhollz RA, Haywood JR. Effects of paraventricular nucleus lesions on chronic renal hypertension. Am J Physiol 1991; 261: H860-67.
57. Buggy J, Fink GD, Johnson AK, Brody MJ. Prevention of the development of renal hypertension by anteroventral third ventricular tissue lesions. Circ Res 1977; 40: I110-17.
58. Johnson AK, Buggy J, Fink GD, Brody MJ. Prevention of renal hypertension and of the central pressor effect of angiotensin by ventromedial hypothalamic ablation. Brain Res 1981; 205: 255-64.
59. Nakata T, Takeda K, Itoh H, Hirata M, Kawasaki S, Hayashi J, et al. Paraventricular nucleus lesions attenuate the development of hypertension in DOCA/salt-treated rats. Am J Hypertens 1989; 2: 625-30.
60. Li YF, Patel KP. Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: The altered inhibitory mechanisms. Acta Physiol Scand 2003; 177: 17-26.
61. Martin DS, Haywood JR. Reduced GABA inhibition of sympathetic function in renal-wrapped hypertensive rats. Am J Physiol Regul Integr Comp Physiol 1998; 275: R1523-29.
62. LaGrange LP, Toney GM, Bishop VS. Effect of intravenous angiotensin II infusion on responses to hypothalamic PVN injection of bicuculline. Hypertension 2003; 42: 1124-29.
63. Verbalis JG, Baldwin EF, Robinson AG. Osmotic regulation of plasma vasopressin and oxytocin after sustained hyponatremia. Am J Physiol Regul Integr Comp Physiol 1986; 250: R444-51.
64. Brooks VL, Haywood JR, Johnson AK. Translation of salt retention to central activation of the sympathetic nervous system in hypertension. Clin Exp Phamacol Physiol 2005; 32: 426-32.
65. Toney GM, Chen QH, Cato MJ, Stocker SD. Central osmotic regulation of sympathetic nerve activity. Acta Physiol Scand 2003; 177: 43-5.
66. Chen QH, Toney GM. AT(1)-receptor blockade in the hypothalamic PVN reduces central hyperosmolality-induced renal sympatho-excitation. Am J Physiol Regul Integr Comp Physiol 2001; 281: R1855-53.
67. Brooks VL, Freeman KL, O'Donaughy TL. Acute and chronic increases in osmolality increase excitatory amino acid drive of the rostral ventrolateral medulla in rats. Am J Physiol Regul Integr Comp Physiol 2004; 287: R1359-68.